Literature DB >> 26231789

Microcirculation in Acute and Chronic Kidney Diseases.

Lara Zafrani1, Can Ince2.   

Abstract

The renal microvasculature is emerging as a key player in acute and chronic kidney diseases. Renal microvascular disease involves alterations in endothelial barrier permeability, exaggerated inflammation, impairment of endothelium-dependent vasorelaxation involving the nitric oxide system, increased oxidative stress, and loss of angiogenic factors. Moreover, evidence suggests that there is a microvascular component to the pathogenesis of renal scarring. New technology is being developed to explore renal microcirculation in vivo in experimental models and humans. This technology will provide a better understanding of the pathogenesis of kidney diseases and will help guide specific therapeutic strategies aimed at restoring the renal microcirculation. This article reviews the cellular and molecular mechanisms of renal microvascular dysfunction in acute and chronic kidney diseases and the potential diagnostic and therapeutic implications of these findings. Recent developments in the monitoring of renal microcirculation are described with respect to their advantages and limitations, and future directions are outlined.
Copyright © 2015 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acute kidney injury (AKI); chronic kidney disease (CKD); endothelium; imaging techniques; microvascular dysfunction; renal microcirculation; tissue hypoxia

Mesh:

Year:  2015        PMID: 26231789     DOI: 10.1053/j.ajkd.2015.06.019

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  26 in total

1.  Interventions for chronic kidney disease in people with sickle cell disease.

Authors:  Noemi Ba Roy; Patricia M Fortin; Katherine R Bull; Carolyn Doree; Marialena Trivella; Sally Hopewell; Lise J Estcourt
Journal:  Cochrane Database Syst Rev       Date:  2016-10

2.  Beraprost sodium mitigates renal interstitial fibrosis through repairing renal microvessels.

Authors:  Shulin Li; Yanping Wang; Lu Chen; Zhuojun Wang; Guodong Liu; Bangjie Zuo; Caixia Liu; Dong Sun
Journal:  J Mol Med (Berl)       Date:  2019-03-28       Impact factor: 4.599

Review 3.  Urine biochemistry assessment in critically ill patients: controversies and future perspectives.

Authors:  Alexandre Toledo Maciel; Daniel Vitorio
Journal:  J Clin Monit Comput       Date:  2016-04-01       Impact factor: 2.502

Review 4.  Interventions for chronic kidney disease in people with sickle cell disease.

Authors:  Noemi Ba Roy; Patricia M Fortin; Katherine R Bull; Carolyn Doree; Marialena Trivella; Sally Hopewell; Lise J Estcourt
Journal:  Cochrane Database Syst Rev       Date:  2017-07-03

Review 5.  Microcirculation: Physiology, Pathophysiology, and Clinical Application.

Authors:  Goksel Guven; Matthias P Hilty; Can Ince
Journal:  Blood Purif       Date:  2019-12-18       Impact factor: 2.614

Review 6.  Understanding and preventing contrast-induced acute kidney injury.

Authors:  Michael Fähling; Erdmann Seeliger; Andreas Patzak; Pontus B Persson
Journal:  Nat Rev Nephrol       Date:  2017-01-31       Impact factor: 28.314

Review 7.  Acute kidney injury and chronic kidney disease: From the laboratory to the clinic.

Authors:  David A Ferenbach; Joseph V Bonventre
Journal:  Nephrol Ther       Date:  2016-03-10       Impact factor: 0.722

8.  PROGRESSION OF CHRONIC KIDNEY DISEASE AFTER ACUTE KIDNEY INJURY.

Authors:  Prasad Devarajan; John Lynn Jefferies
Journal:  Prog Pediatr Cardiol       Date:  2016-06

9.  Microvascular rarefaction and hypertension in the impaired recovery and progression of kidney disease following AKI in preexisting CKD states.

Authors:  Aaron J Polichnowski
Journal:  Am J Physiol Renal Physiol       Date:  2018-09-26

Review 10.  The renal microcirculation in chronic kidney disease: novel diagnostic methods and therapeutic perspectives.

Authors:  Shulin Li; Fei Wang; Dong Sun
Journal:  Cell Biosci       Date:  2021-05-17       Impact factor: 7.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.